全文获取类型
收费全文 | 542084篇 |
免费 | 155657篇 |
国内免费 | 8298篇 |
专业分类
706039篇 |
出版年
2018年 | 6205篇 |
2017年 | 5662篇 |
2016年 | 7700篇 |
2015年 | 10523篇 |
2014年 | 11598篇 |
2013年 | 15182篇 |
2012年 | 17441篇 |
2011年 | 18002篇 |
2010年 | 14182篇 |
2009年 | 17970篇 |
2008年 | 16688篇 |
2007年 | 17007篇 |
2006年 | 14669篇 |
2005年 | 14516篇 |
2004年 | 14250篇 |
2003年 | 13247篇 |
2002年 | 13475篇 |
2001年 | 25419篇 |
2000年 | 23512篇 |
1999年 | 23077篇 |
1998年 | 13614篇 |
1997年 | 13509篇 |
1996年 | 12828篇 |
1995年 | 12624篇 |
1994年 | 12095篇 |
1993年 | 11604篇 |
1992年 | 19718篇 |
1991年 | 18942篇 |
1990年 | 19242篇 |
1989年 | 18543篇 |
1988年 | 16707篇 |
1987年 | 15638篇 |
1986年 | 14383篇 |
1985年 | 13816篇 |
1984年 | 11344篇 |
1983年 | 9610篇 |
1982年 | 8390篇 |
1981年 | 7565篇 |
1980年 | 7191篇 |
1979年 | 10326篇 |
1978年 | 8332篇 |
1977年 | 7790篇 |
1976年 | 7250篇 |
1975年 | 7213篇 |
1974年 | 7907篇 |
1973年 | 7787篇 |
1972年 | 7455篇 |
1971年 | 6898篇 |
1970年 | 5911篇 |
1969年 | 5866篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
991.
H C Freeman T P Garrett J M Guss M Murata F Yoshizaki Y Sugimura M Shimokoriyama 《Journal of molecular biology》1983,164(2):351-353
The plastocyanins from a green alga (Enteromorpha prolifera) and cucumber (Cucumis sativus) have been crystallized. Crystal data are as follows: E. prolifera plastocyanin, space group I4, a = b = 53.9 A, c = 59.4 A, Z = 8; C. sativus plastocyanin, space group P4(1) (or P4(3) ), a = b = 66.7 A, c = 46.0 A, Z = 8. Accordingly, the asymmetric units of the crystals contain one and two molecules, respectively. 相似文献
992.
Abstract The respiratory activity of cysts of Azotobacter vinelandii has been compared with that of vegetative cells. Whole cysts had a much reduced respiratory activity which was less sensitive to KCN. Substrate oxidation rates by membrane preparations from cysts were reduced approximately 10-fold and sensitivity to KCN was decreased by a similar factor. Difference spectra of cyst membranes revealed changes in cytochrome content. Cytochrome oxidase d was apparently absent, cytochrome a 1 levels were approximately halved whilst those of cytochrome oxidase o were almost doubled. Cytochromes of the b and c -type were present in similar amounts to those in vegetative cells. 相似文献
993.
Frederick C. Wedler Michael C. Vichnin Brenda W. Ley Georges Tholey Marc Ledig Jean-Christoph Copin 《Neurochemical research》1994,19(2):145-151
Previous studies have demonstrated that in glia and astrocytes Mn(II) is distributed with ca. 30–40% in the cytoplasm, 60–70% in mitochondria. Ca(II) ions were observed to alter both the flux rates and distribution of Mn(II) ions in primary cultues of chick glia and rat astrocytes. External (influxing) Ca(II) ions had the greatest effect on Mn(II) uptake and efflux, compared to internal (effluxing) or internal-external equilibrated Ca(II) ions. External (influxing) Ca(II) ions inhibited the net rate and extent of Mn(II) uptake but enhanced Mn(II) efflux from mitochondria. These observations differ from Ca(II)–Mn(II) effects previously reported with brain (neuronal) mitochondria. Overall, increased cytoplasmic Ca(II) acts to block Mn(II) uptake and enhance Mn(II) release by mitochondria, which serve to increase the cytoplasmic concentration of free Mn(II). A hypothesis is presented involving external L-glutamate acting through membrane receptors to mobilize cell Ca(II), which in turn causes mitochondrial Mn(II) to be released. Because the concentration of free cytoplasmic Mn(II) is poised near the Kd for Mn(II) with glutamine synthetase, a slight increase in cytoplasmic Mn(II) will directly enhance the activity of glutamine synthetase, which catalyzes removal of neurotoxic glutamate and ammonia. 相似文献
994.
The effect of flooding on aerobic and anaerobic respirationas well as on the internal levels of ethanol, lactic, succinicand malic acids were compared in three flood-tolerant and twonon-flood-tolerant species. In the non-flood-tolerant speciesKielmeyera coriacea and Pseudobombax marginatum, which comefrom the cerrado vegetation, there was a uniformityof response with ethanol being the only one of the above productsto accumulate substantially during flooding. In the flood-tolerantspecies, Sebastiana klotzchyana, Hymenaea courbaril var. stilbocarpaand Chorisia speciosa, flooding induced a variety of responseswhich indicate that the tolerant species have evolved differingstrategies to overcome flooding stress. 相似文献
995.
AIMS: To identify physical and physiological conditions that affect the survival of Sinorhizobium meliloti USDA 1021 during desiccation. METHODS AND RESULTS: An assay was developed to study desiccation response of S. meliloti USDA 1021 over a range of environmental conditions. We determined the survival during desiccation in relation to (i) matrices and media, (ii) growth phase, (iii) temperature, and (iv) chloride and sulfate availability. CONCLUSIONS: This study indicates that survival of S. meliloti USDA 1021 during desiccation is enhanced: (i) when cells were dried in the stationary phase, (ii) with increasing drying temperature at an optimum of 37 degrees C, and (iii) during an increase of chloride and sulfate, but not sodium or potassium availability. In addition, we resolved that the best matrix to test survival was nitrocellulose filters. SIGNIFICANCE AND IMPACT OF THE STUDY: The identification of physical and physiological factors that determine the survival during desiccation of S. meliloti USDA 1021 may aid in (i) the strategic development of improved seed inocula, (ii) the isolation, and (iii) the development of rhizobial strains with improved ability to survive desiccation. Furthermore, this work may provide insights into the survival of rhizobia under drought conditions. 相似文献
996.
Hewavitharana AK Hyde C Thomas R Shaw PN 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》2006,834(1-2):93-97
During the analytical method development for BAY 11-7082 ((E)-3-[4-methylphenylsulfonyl]-2-propenenitrile), using HPLC-MS-MS and HPLC-UV, we observed that the protein removal process (both ultrafiltration and precipitation method using organic solvents) prior to HPLC brought about a significant reduction in the concentration of this compound. The use of a structurally similar internal standard, BAY 11-7085 ((E)-3-[4-t-butylphenylsulfonyl]-2-propenenitrile), was not effective in compensating for the loss of analyte as the extent of reduction was different to that of the analyte. We present here a systematic investigation of this problem and a new validated method for the determination of BAY 11-7082. 相似文献
997.
998.
Gold containing Ayurvedic preparation, Swarna Vasant Malti, was given to 20 male persons in a dose of 100 mg twice a day for 40 days under supervision of Ayurvedic physicians. The total cumulative intake of 160 mg of gold at the rate of 4 mg per day in this form did not have any toxic effect on human body as evidenced by clinical examination, unaltered body weight, absence of urinary pathology and by 30 sensitive biochemical and enzymatic tests. The gold from this Ayurvedic preparation was found in plasma and erythrocytes, excreted partly in urine and was present in semen. Gold binding to albumin and hemoglobin slightly increased their electrophoretic mobility towards anode. This gold preparation seemed to increase sperm motility and prostatic activity. 相似文献
999.
Sharma S Sundaram CS Luthra PM Singh Y Sirdeshmukh R Gade WN 《Journal of biotechnology》2006,126(3):374-382
The genus Pseudomonas is a group of gram-negative, motile, rod-shaped bacteria known for their metabolic versatility. One of the species is Pseudomonas fluorescens, which has an efficient system for detoxification of industrial waste. Other aspects include, catabolic versatility, excellent root colonizing abilities and capacity to produce a wide range of antifungal metabolites. They are also known for their resistance and survival in the presence of several organic and inorganic pollutants. P. fluorescens has also been isolated from metal polluted water and soils but the elucidation of proteins responsible for its survival is still not clear. The aim of the study was to elucidate the differential protein expression of this bacterium when exposed to heavy metal stress, using two-dimensional electrophoresis. The proteins spo VG and enolase showed upregulation during the bacterial exposure to lead and copper. Hypothetical protein showed downregulation when bacterium was exposed to cobalt. Some proteins like xylosyltransferase, ORF 18 phage phi KZ, OMP H1 and translational elongation factor EF-Tu appeared only during their exposure to cobalt. These were absent in the control condition. Analysis of the differentially expressed proteins as well as the newly synthesized proteins along with the results obtained growth and enzyme activity indicate the involvement of all these factors in the survival of this organism in the presence of heavy metals. 相似文献
1000.
Francisco J. Roig A. Llorens B. Fouz C. Amaro 《Applied and environmental microbiology》2009,75(8):2577-2580
This work demonstrates that Vibrio vulnificus biotype 2, serovar E, an eel pathogen able to infect humans, can become resistant to quinolone by specific mutations in gyrA (substitution of isoleucine for serine at position 83) and to some fluoroquinolones by additional mutations in parC (substitution of lysine for serine at position 85). Thus, to avoid the selection of resistant strains that are potentially pathogenic for humans, antibiotics other than quinolones must be used to treat vibriosis on farms.Vibrio vulnificus is an aquatic bacterium from warm and tropical ecosystems that causes vibriosis in humans and fish (http://www.cdc.gov/nczved/dfbmd/disease_listing/vibriov_gi.html) (33). The species is heterogeneous and has been subdivided into three biotypes and more than eight serovars (6, 15, 33; our unpublished results). While biotypes 1 and 3 are innocuous for fish, biotype 2 can infect nonimmune fish, mainly eels, by colonizing the gills, invading the bloodstream, and causing death by septicemia (23). The disease is rapidly transmitted through water and can result in significant economic losses to fish farmers. Surviving eels are immune to the disease and can act as carriers, transmitting vibriosis between farms. Interestingly, biotype 2 isolates belonging to serovar E have been isolated from human infections, suggesting that serovar E is zoonotic (2). This serovar is also the most virulent for fish and has been responsible for the closure of several farms due to massive losses of fish. A vaccine, named Vulnivaccine, has been developed from serovar E isolates and has been successfully tested in the field (14). Although the vaccine provides fish with long-term protection from vibriosis, at present its use is restricted to Spain. For this reason, in many fish farms around the world, vibriosis is treated with antibiotics, which are usually added to the food or water.Quinolones are considered the most effective antibiotics against human and fish vibriosis (19, 21, 31). These antibiotics can persist for a long time in the environment (20), which could favor the emergence of resistant strains under selective pressure. In fact, spontaneous resistances to quinolones by chromosomal mutations have been described for some gram-negative bacteria (10, 11, 17, 24, 25, 26). Therefore, improper antibiotic treatment of eel vibriosis or inadequate residue elimination at farms could favor the emergence of human-pathogenic serovar E strains resistant to quinolones by spontaneous mutations. Thus, the main objective of the present work was to find out if the zoonotic serovar of biotype 2 can become quinolone resistant under selective pressure and determine the molecular basis of this resistance.Very few reports on resistance to antibiotics in V. vulnificus have been published; most of them have been performed with biotype 1 isolates. For this reason, the first task of this study was to determine the antibiotic resistance patterns in a wide collection of V. vulnificus strains belonging to the three biotypes that had been isolated worldwide from different sources (see Table S1 in the supplemental material). Isolates were screened for antimicrobial susceptibility to the antibiotics listed in Table S1 in the supplemental material by the agar diffusion disk procedure of Bauer et al. (5), according to the standard guideline (9). The resistance pattern found for each isolate is shown in Table S1 in the supplemental material. Less than 14% of isolates were sensitive to all the antibiotics tested, and more than 65% were resistant to more than one antibiotic, irrespective of their biotypes or serovars. The most frequent resistances were to ampicillin-sulbactam (SAM; 65.6% of the strains) and nitrofurantoin (F; 60.8% of the strains), and the least frequent were to tetracycline (12%) and oxytetracycline (8%). In addition, 15% of the strains were resistant to nalidixic acid (NAL) and oxolinic acid (OA), and 75% of these strains came from fish farms (see Table S1 in the supplemental material). Thus, high percentages of strains of the three biotypes were shown to be resistant to one or more antibiotics, with percentages similar to those found in nonbiotyped environmental V. vulnificus isolates from Asia and North America (4, 27, 34). In those studies, resistance to antibiotics could not be related to human contamination. However, the percentage of quinolone-resistant strains found in our study is higher than that reported in other ones, probably due to the inclusion of fish farm isolates, where the majority of quinolone-resistant strains were concentrated. This fact suggests that quinolone resistance could be related to human contamination due to the improper use of these drugs in therapy against fish diseases, as has been previously suggested (18, 20). Although no specific resistance pattern was associated with particular biotypes or serovars, we found certain differences in resistance distribution, as shown in Table Table1.1. In this respect, biotype 3 displayed the narrowest spectrum of resistances and biotype 1 the widest. The latter biotype encompassed the highest number of strains with multiresistance (see Table S1 in the supplemental material). Within biotype 2, there were differences among serovars, with quinolone resistance being restricted to the zoonotic serovar (Table (Table11).
Open in a separate windowaCTX, cefotaxime; E, erythromycin; OT, oxytetracycline; SXT-TMP, sulfamethoxazole-trimethoprim; TE, tetracycline.The origin of resistance to quinolones in the zoonotic serovar was further investigated. To this end, spontaneous mutants of sensitive strains were selected from colonies growing within the inhibition halo around OA or NAL disks. Two strains (strain CG100 of biotype 1 and strain CECT 4604 of biotype 2, serovar E) developed isolated colonies within the inhibition zone. These colonies were purified, and maintenance of resistance was confirmed by serial incubations on medium without antibiotics. Using the disk diffusion method, CG100 was shown to be resistant to SAM and F and CECT 4604 to F (see Table S1 in the supplemental material). The MICs for OA, NAL, flumequine (UB), and ciprofloxacin (CIP) were determined by using the microplate assay according to the recommendations of the Clinical and Laboratory Standards Institute and the European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology and Infectious Diseases (8, 12) and interpreted according to the European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology and Infectious Diseases (13). The MICs for OA and NAL and for the fluoroquinolones UB and CIP exhibited by the mutants and their counterparts are shown in Table Table2.2. The inhibition zone diameters correlated well with MICs (data not shown). Mutants FR1, FR2, FR3, and FR4 were resistant to NAL and sensitive to the remaining quinolones, although they showed higher resistances than their parental strains (Table (Table2).2). Thus, these four mutants showed increases of 32- to 128-fold for NAL MICs, 4- to 8-fold for UB MICs, and 16-fold for CIP MICs (Table (Table2).2). The fifth mutant, FR5, was resistant to the two tested quinolones and to UB, a narrow-spectrum fluoroquinolone. This mutant, although sensitive to CIP, multiplied its MIC for this drug by 128 with respect to the parental strain (Table (Table22).
Open in a separate windowaMutations in a nucleotide (nt) that gave rise to a codon change and to a change in amino acids (aa) are indicated. NC, no change detected.bThe resistance (R) or sensitivity (S) against the antibiotic determined according to the Clinical and Laboratory Standards Institute and the European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology and Infectious Diseases (9, 13) is indicated in parentheses.For other gram-negative pathogens, quinolone resistance relies on spontaneous mutations in the gyrA, gyrB, parC, and parE genes that occur in a specific region of the protein known as the quinolone resistance-determining region (QRDR) (1, 11, 17, 24, 25, 26, 28). To test the hypothesis that mutations in these genes could also produce quinolone resistance in V. vulnificus, the QRDRs of these genes were sequenced in the naturally resistant strains and in the two sensitive strains that had developed resistances by selective pressure in vitro. The genomic DNA was extracted (3), and the QRDRs of gyrA, gyrB, parE, and parC were amplified using the primers shown in Table Table3,3, which were designed from the published genomes of biotype 1 strains YJ016 and CMCP6 (7, 22). PCR products of the predicted size were sequenced in an ABI 3730 sequencer (Applied Biosystems). Analysis of the QRDR sequences for gyrA, gyrB, parC, and parE of the mutants and the naturally resistant strains revealed that all naturally resistant strains, except one, shared a specific mutation at nucleotide position 248 with the laboratory-induced mutants (Table (Table2).2). This mutation gave rise to a change from serine to isoleucine at amino acid position 83. The exception was a mutation in the adjacent nucleotide that gave rise to a substitution of arginine for serine at the same amino acid position (Table (Table2).2). All the isolates that were resistant to the quinolone NAL had a unique mutation in the gyrA gene, irrespective of whether resistance was acquired naturally or in the laboratory (Table (Table2).2). This result strongly suggests that a point mutation in gyrA that gives rise to a change in nucleotide position 83 can confer resistance to NAL in V. vulnificus biotypes 1 and 2 and that this mutation could be produced by selective pressure under natural conditions. gyrA mutations consisting of a change from serine 83 to isoleucine have also been described in isolates of Aeromonas from water (17) and in diseased fish isolates of Vibrio anguillarum (26). Similarly, replacement of serine by arginine at amino acid position 83 in diseased fish isolates of Yersinia ruckeri (16) suggests that this mechanism of quinolone resistance is widespread among gram-negative pathogens. In all cases, these single mutations were also related to increased resistance to other quinolones (OA) and fluoroquinolones (UB and CIP) (Table (Table2),2), although the mutants remained sensitive according to the standards of the Clinical and Laboratory Standards Institute and the European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology and Infectious Diseases (9, 13). A total of 50% of the naturally resistant strains, all of them of biotype 1, showed additional mutations that affected parC (a change in amino acid position 113) or gyrB (changes in amino acids at positions 425 and 438) (Table (Table2).2). These strains exhibited higher MICs for OA and fluoroquinolones (Table (Table2),2), although they were still sensitive to these drugs (9, 13). Finally, one isolate of biotype 2, serovar E, which was naturally resistant to quinolones and UB, showed a mutation in parC that gave rise to a substitution of leucine for serine at amino acid position 85 (Table (Table2).2). This mutation was shared only with the laboratory-induced mutant, also a biotype 2, serovar E mutant, which was resistant to the fluoroquinolone UB. The same mutation in parC had been previously described in diseased fish isolates of V. anguillarum that were highly resistant to quinolones (28), but this had not been related to fluoroquinolone resistance in Vibrio spp. nor in other gram-negative bacteria. These results strongly suggest that resistance to fluoroquinolones in V. vulnificus is related to specific mutations in gyrA and parC and that mutations in different positions for parC or in gyrB could contribute to increased resistance to quinolones and fluoroquinolones. Our results also agree with previous studies confirming that the acquisition of higher quinolone resistance is more probable when arising from a gyrA parC double mutation than from a gyrA gyrB double mutation (29).
Open in a separate windowFinally, the evolutionary history for each protein was inferred from previously published DNA sequences of the whole genes from different Vibrio species after multiple sequence alignment with MEGA4 software (32) by applying the neighbor-joining method (30) with the Poisson correction (35). The distance tree for each whole protein showed a topology similar to the phylogenetic tree based on 16S rRNA analysis, with the two isolates of V. vulnificus forming a single group, closely related to Vibrio parahaemolyticus, Vibrio cholerae, V. anguillarum, and Vibrio harveyi (see Fig. S1A in the supplemental material). A second analysis was performed with the QRDR sequences of the different mutants and isolates of V. vulnificus (GenBank accession numbers ) to infer the intraspecies relationships (see Fig. S1B in the supplemental material). This analysis showed that QRDRs of gyrA, gyrB, parC, and parE were highly homogeneous within V. vulnificus.In summary, the zoonotic serovar of V. vulnificus can mutate spontaneously to gain quinolone resistance, under selective pressure in vitro, due to specific mutations in gyrA that involve a substitution of isoleucine for serine at amino acid position 83. This mutation appears in biotype 2, serovar E diseased-fish isolates and biotype 1 strains, mostly recovered from fish farms. An additional mutation in parC, resulting in a substitution of lysine for serine at amino acid position 85, seems to endow partial fluoroquinolone resistance on biotype 2, serovar E strains. This kind of double mutation is present in diseased-fish isolates of the zoonotic serovar but not in resistant biotype 1 isolates, which show different mutations in gyrB or in parC that increase their resistance levels but do not make the strains resistant to fluoroquinolones. Thus, antibiotics other than quinolones should be used at fish farms to prevent the emergence and spread of quinolone resistances, especially to CIP, a drug widely recommended for human vibriosis treatment. FJ379836 to FJ379927 相似文献
TABLE 1.
Percentage of resistant strains distributed by biotypes and serovarsV. vulnificus | No. of isolates | Resistance distribution (%) for indicated antibiotica
| ||||||||
---|---|---|---|---|---|---|---|---|---|---|
SAM | CTX | E | NAL | F | OT | OA | SXT-TMP | TE | ||
Biotype 1 | 49 | 75.5 | 24.5 | 14.3 | 30.6 | 83.7 | 8.2 | 30.6 | 28.6 | 8.2 |
Biotype 2 (whole) | 72 | 58.3 | 13.9 | 12.5 | 4.2 | 47.2 | 9.7 | 4.2 | 4.2 | 13.9 |
Biotype 2 | ||||||||||
Serovar E | 36 | 30.3 | 12.1 | 3 | 9.1 | 27.3 | 15.2 | 9.1 | 3 | 21.2 |
Serovar A | 23 | 100 | 9.1 | 18.2 | 0 | 77.3 | 0 | 0 | 9.1 | 4.6 |
Nontypeable | 8 | 29 | 14.3 | 25 | 0 | 57.1 | 14.3 | 0 | 0 | 14.3 |
Serovar I | 5 | 100 | 20 | 20 | 0 | 20 | 20 | 0 | 0 | 0 |
Biotype 3 | 5 | 100 | 0 | 20 | 0 | 80 | 0 | 0 | 0 | 20 |
TABLE 2.
MICs for quinolones and fluoroquinolones and mutations in gyrA, gyrB, and parC detected in naturally and artificially induced resistant strainsStrain(s) | MIC (μg ml−1) for indicated antibioticb
| Gene mutationa
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
gyrA
| gyrB
| parC
| ||||||||||||||
Position
| Codon change | aa change | Position
| Codon change | aa change | Position
| Codon change | aa change | ||||||||
NAL | OA | UB | CIP | nt | aa | nt | aa | nt | aa | |||||||
CG100 | 0.5 (S) | 0.125 (S) | 0.0625 (S) | 0.0078 (S) | ||||||||||||
FR1 | 16 (R) | 1 (S) | 0.25 (S) | 0.125 (S) | 248 | 83 | AGT→ATT | S→I | NC | NC | NC | NC | NC | NC | NC | NC |
FR2 | 16 (R) | 1 (S) | 0.25 (S) | 0.125 (S) | 248 | 83 | AGT→ATT | S→I | NC | NC | NC | NC | NC | NC | NC | NC |
CECT 4604 | 0.25 (S) | 0.0625 (S) | 0.0625 (S) | 0.0078 (S) | ||||||||||||
FR3 | 32 (R) | 2 (S) | 0.5 (S) | 0.125 (S) | 248 | 83 | AGT→ATT | S→I | NC | NC | NC | NC | NC | NC | NC | NC |
FR4 | 32 (R) | 2 (S) | 0.5 (S) | 0.125 (S) | 248 | 83 | AGT→ATT | S→I | NC | NC | NC | NC | NC | NC | NC | NC |
FR5 | 256 (R) | 16 (R) | 16 (R) | 1 (S) | 248 | 83 | AGT→ATT | S→I | 1156 | 386 | GCA→ACA | A→T | 254 | 85 | TCA→TTA | S→L |
1236 | 412 | CAG→CAC | Q→H | |||||||||||||
CECT 4602 | 128 (R) | 8 (R) | 64 (R) | 1 (S) | 248 | 83 | AGT→ATT | S→I | NC | NC | NC | NC | 254 | 85 | TCA→TTA | S→L |
CECT 4603, CECT 4606, CECT 4608, PD-5, PD-12, JE | 32 (R) | 2 (S) | <1 (S) | <1 (S) | 248 | 83 | AGT→ATT | S→I | NC | NC | NC | NC | NC | NC | NC | NC |
CECT 4862 | 64 (R) | 2 (S) | 2 (S) | <1 (S) | 249 | 83 | AGT→AGA | S→R | NC | NC | NC | NC | NC | NC | NC | NC |
A2, A4, A5, A6, A7, PD-1, PD-3 | 64-128 (R) | 2 (S) | 4 (S) | <1 (S) | 248 | 83 | AGT→ATT | S→I | NC | NC | NC | NC | 338 | 113 | GCA→GTA | A→V |
V1 | 128 (R) | 4 (S) | 4 (S) | <1 (S) | 248 | 83 | AGT→ATT | S→I | 1274 | 425 | GAG→GGG | E→G | NC | NC | NC | NC |
1314 | 438 | AAC→AAA | N→K |
TABLE 3.
Oligonucleotides used in this studyPrimer | Sequence | Annealing temp (°C) | Size (bp) |
---|---|---|---|
GyrAF | GGCAACGACTGGAATAAACC | 55.8 | 416 |
GyrAR | CAGCCATCAATCACTTCCGTC | ||
ParCF | CGCAAGTTCACCGAAGATGC | 56.6 | 411 |
ParCR | GGCATCCGCAACTTCACG | ||
GyrBF | CGACTTCTGGTGACGATGCG | 57.4 | 642 |
GyrBR | GACCGATACCACAACCTAGTG | ||
ParEF | GCCAGGTAAGTTGACCGATTG | 56.8 | 512 |
ParER | CACCCAGACCTTTGAATCGTTG |